Literature DB >> 20306053

Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience.

Chen Zhong1, Sanwei Guo, Yueqing Tang, Shujie Xia.   

Abstract

OBJECTIVES: To evaluate the efficacy and safety of 2 micron continuous wave laser resection of non-muscle-invasive bladder tumor (NMIBT) compared with holmium laser resection of bladder tumor (HoLRBT) and standard transurethral resection of bladder tumor (TURBT).
METHODS: Since April 2006 to August 2007, 97 patients with NMIBT were retrospectively collected in this study. All of them were classified into 3 groups, which were treated with 2 micron continuous wave laser resection, holmium laser resection and TURBT, respectively. The preoperative, intraoperative and postoperative clinical data were recorded and compared using SAS 6.12 statistical software.
RESULTS: There were no differences with the preoperative characteristics among the three groups, except the diameter of the tumors. The maximum diameter of the tumors in 2 micron laser group was larger than the other two groups (P < 0.05). Two micron laser group was associated with less hemoglobin decrease compared with TURBT group (P < 0.05). All of the patients were followed and the recurrence rate of the three groups indicated no statistical significance (P > 0.05).
CONCLUSIONS: In conclusion, 2 micron continuous wave laser resection of non-muscle-invasive bladder tumor is a safe and reliable treatment. With the distinguished hemostasis, it is an available optional treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20306053     DOI: 10.1007/s00345-010-0532-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

1.  High-power thulium fiber laser ablation of urinary tissues at 1.94 microm.

Authors:  Nathaniel M Fried; Keith E Murray
Journal:  J Endourol       Date:  2005 Jan-Feb       Impact factor: 2.942

2.  StatBite: A look at bladder cancer in the United States.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2009-10-30       Impact factor: 13.506

3.  Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.

Authors:  Andreas Böhle; Herbert Leyh; Christian Frei; Michael Kühn; Reinhold Tschada; Tobias Pottek; Walter Wagner; Helmut H Knispel; Wolfgang von Pokrzywnitzki; Ferruh Zorlu; Karin Helsberg; Birgit Lübben; Victoria Soldatenkova; Clemens Stoffregen; Hartwig Büttner
Journal:  Eur Urol       Date:  2009-06-21       Impact factor: 20.096

4.  Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience.

Authors:  H A Syed; C S Biyani; N Bryan; S J Brough; C S Powell
Journal:  J Endourol       Date:  2001-08       Impact factor: 2.942

5.  Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.

Authors:  Willie Underwood; Rodney L Dunn; Candice Williams; Cheryl T Lee
Journal:  J Am Coll Surg       Date:  2005-12-19       Impact factor: 6.113

Review 6.  Gender, racial and age differences in bladder cancer incidence and mortality.

Authors:  Ralph Madeb; Edward M Messing
Journal:  Urol Oncol       Date:  2004 Mar-Apr       Impact factor: 3.498

7.  Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.

Authors:  Song Xishuang; Yang Deyong; Che Xiangyu; Jiang Tao; Li Quanlin; Guan Hongwei; Yin Jibin; Wu Dongjun; He Zhongzhou; Wang Jianbo; Wang Lina; Ye Lin
Journal:  J Endourol       Date:  2010-01       Impact factor: 2.942

8.  [Continuous wave laser of 2 microm for bladder tumor treatment].

Authors:  Yong Yang; Bao-Fa Hong; Zhi-Tao Wei
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2008-09-15

9.  Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial.

Authors:  Shu-Jie Xia; Jian Zhuo; Xiao-Wen Sun; Bang-Min Han; Yi Shao; Yi-Nan Zhang
Journal:  Eur Urol       Date:  2007-06-04       Impact factor: 20.096

Review 10.  Lasers in clinical urology: state of the art and new horizons.

Authors:  Andrew J Marks; Joel M H Teichman
Journal:  World J Urol       Date:  2007-03-28       Impact factor: 3.661

View more
  20 in total

Review 1.  [En bloc resection and vaporization techniques for the treatment of bladder cancer].

Authors:  J P Struck; A Karl; C Schwentner; T R W Herrmann; M W Kramer
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

2.  En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial.

Authors:  Xu Chen; Jun Liao; Lingwu Chen; Shaopeng Qiu; Chengqiang Mo; Xiaopeng Mao; Yuanzhong Yang; Shiying Zhou; Junxing Chen
Journal:  World J Urol       Date:  2014-06-21       Impact factor: 4.226

Review 3.  [Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?].

Authors:  M W Kramer; M Wolters; I F Abdelkawi; A S Merseburger; U Nagele; A Gross; T Bach; M A Kuczyk; T R W Herrmann
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

4.  Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis.

Authors:  Huan Yang; Ning Wang; Shanfu Han; Musa Male; Chenming Zhao; Daqiang Yao; Zhiqiang Chen
Journal:  Lasers Med Sci       Date:  2017-08-23       Impact factor: 3.161

5.  Two-micron thulium laser resection of the distal ureter and bladder cuff during nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Kun Pang; Shi-bo Liu; Hai-bin Wei; Jian Zhuo; Mei-li Li; Shu-jie Xia; Xiao-wen Sun
Journal:  Lasers Med Sci       Date:  2013-06-23       Impact factor: 3.161

6.  Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience.

Authors:  Mathias Wolters; Mario W Kramer; Jan U Becker; Matthias Christgen; Udo Nagele; Florian Imkamp; Martin Burchardt; Axel S Merseburger; Markus A Kuczyk; Thorsten Bach; Andreas J Gross; Thomas R W Herrmann
Journal:  World J Urol       Date:  2011-05-08       Impact factor: 4.226

Review 7.  Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis.

Authors:  Gongwei Long; Yucong Zhang; Guoliang Sun; Wei Ouyang; Zheng Liu; Heng Li
Journal:  Lasers Med Sci       Date:  2021-02-18       Impact factor: 3.161

Review 8.  Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer.

Authors:  Mario W Kramer; Thorsten Bach; Mathias Wolters; Florian Imkamp; Andreas J Gross; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2011-05-05       Impact factor: 4.226

9.  En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor.

Authors:  Mario W Kramer; Jens J Rassweiler; Jan Klein; Alexey Martov; Nikolay Baykov; Lukas Lusuardi; Günter Janetschek; Rodolfo Hurle; Mathias Wolters; Mahmoud Abbas; Christoph A von Klot; Armin Leitenberger; Markus Riedl; Udo Nagele; Axel S Merseburger; Markus A Kuczyk; Marko Babjuk; Thomas R W Herrmann
Journal:  World J Urol       Date:  2015-04-25       Impact factor: 4.226

Review 10.  Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014.

Authors:  Mario W Kramer; Mathias Wolters; Hannes Cash; Stephan Jutzi; Florian Imkamp; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2014-06-17       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.